Celcuity has won FDA approval for gedatolisib – its first product – as a treatment for patients with a particular form of ...
An alarming study has found that people who suffer a serious heart attack are more likely to have micro and nanoplastics ...
Fresh from signing an alliance with Novartis, Chai Discovery has raised $400 million in a third-round financing to support ...
What receives far less attention is what happens to the data that was stolen before the encryption even started, and where it ends up in the weeks and months that follow. TrendAI’s latest research ...
New biotech Avere Therapeutics has taken a fast-track to becoming a publicly listed company by merging with NextCure, with a ...
After a delay, Eisai and Biogen have won FDA approval for their new subcutaneous formulation of Alzheimer's disease therapy ...
Spero Therapeutics has licensed rights to an anti-CD40L antibody developed by China's Innovent Biologics, planning to develop ...
The University of Oxford has launched what it says is the world's first phase I clinical trial of a vaccine specifically ...
A study has shown that, for people living with advanced cancer, a simple, weekly remote check-in with their care team can ...
AstraZeneca has continued its pipeline-boosting deal spree in China with a $1.5 billion agreement that gives it global rights ...
A large-scale trial has been launched, with $100 million in backing, to explore whether lifestyle changes coupled with GLP-1 ...
Biogen and Ionis have revealed the first clinical results with tau-targeting Alzheimer's drug candidate diranersen, showing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results